{"id":448842,"date":"2021-03-02T16:08:19","date_gmt":"2021-03-02T21:08:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=448842"},"modified":"2021-03-02T16:08:19","modified_gmt":"2021-03-02T21:08:19","slug":"reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/","title":{"rendered":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BELTSVILLE, Md., March  02, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=t1242r0PUoVetuzm6PvbSJdnsz_YT84NRl5-WsDgqbSS248CItAzWb9jv12ZK_pEkdLYMo_gN2xD8s6AfDssdQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">NextCure, Inc.<\/a> (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a Virtual R&amp;D Update Event at 5:00 p.m. ET on Thursday, March 4.<\/p>\n<p>The event will be available via conference call and webcast. To listen to the call, please dial:<\/p>\n<p>US\/CANADA Toll-Free Dial-In Number: (877) 665-6632<br \/>International Dial-In Number: (602) 563-8471<br \/>Conference ID: 6773907<\/p>\n<p>A live webcast of the event will be available through the Investors section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3qMe6GsX0X1cb_IuGqgkWkMQDblQDdrWVe-zu6FqIg8EYZQwkmHUF9hWriuj3JDE5JoGt7mowD-UiWZgA0dBWg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.nextcure.com<\/a>. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days.<\/p>\n<p>\n        <strong>About NextCure, Inc.<\/strong><br \/>\n        <br \/>NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our proprietary FIND-IO\u2122 platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Our initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3qMe6GsX0X1cb_IuGqgkWhwxxSdwgt6sez7cnXHiJL5AWrlcXw6DpRq5UP1b7FRU7KiV-HGF3WnU1_z8ENVjFg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.nextcure.com<\/a><\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements, including statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, assumptions and other information available to NextCure as of the date hereof. Forward-looking statements include statements regarding NextCure\u2019s expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as \u201cmay,\u201d \u201cwill,\u201d \u201cpotential,\u201d \u201cexpects,\u201d \u201cbelieves,\u201d \u201cintends,\u201d \u201chope,\u201d \u201ctowards,\u201d \u201cforward,\u201d \u201clater\u201d and similar expressions. Examples of forward-looking statements in this press release include, among others, statements about the progress and evaluation and expected timing of results of NextCure\u2019s ongoing clinical trial of NC318, expectations regarding the potential benefits, activity, effectiveness and safety of NC318, the evaluation of biomarkers, the expected timing of results of NextCure\u2019s ongoing clinical trial of NC410 and NextCure\u2019s plans, objectives and intentions with respect to the discovery and development of immunomedicines. Forward-looking statements involve substantial risks and uncertainties that could cause actual results to differ materially from those projected in any forward-looking statement. Such risks and uncertainties include, among others: the impacts of the COVID-19 pandemic on NextCure\u2019s business, including NextCure\u2019s clinical trials, third parties on which NextCure relies and NextCure\u2019s operations; positive results in preclinical studies may not be predictive of the results of clinical trials; NextCure\u2019s limited operating history and no products approved for commercial sale; NextCure\u2019s history of significant losses; NextCure\u2019s need to obtain additional financing; risks related to clinical development, marketing approval and commercialization; the unproven approach to the discovery and development of product candidates based on NextCure\u2019s FIND-IO platform; and dependence on key personnel. More detailed information on these and additional factors that could affect NextCure\u2019s actual results are described in NextCure\u2019s filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including NextCure\u2019s most recent Form 10-K and subsequent Form 10-Q. You should not place undue reliance on any forward-looking statements. Forward-looking statements speak only as of the date of this press release, and NextCure assumes no obligation to update any forward-looking statements, even if expectations change.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b89ab42f-30ef-4705-92a5-77fc3c6d1c4d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Inquiries\r\nTimothy Mayer, Ph.D.\r\nNextCure, Inc.\r\nChief Operating Officer\r\n(240) 762-6486\r\nIR@nextcure.com\r\n\r\nMedia Inquiries\r\nEmily Wong\r\nMacDougall\r\n(781) 235-3060\r\nNextCure@macbiocom.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BELTSVILLE, Md., March 02, 2021 (GLOBE NEWSWIRE) &#8212; NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a Virtual R&amp;D Update Event at 5:00 p.m. ET on Thursday, March 4. The event will be available via conference call and webcast. To listen to the call, please dial: US\/CANADA Toll-Free Dial-In Number: (877) 665-6632International Dial-In Number: (602) 563-8471Conference ID: 6773907 A live webcast of the event will be available through the Investors section of the company\u2019s website at www.nextcure.com. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-448842","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BELTSVILLE, Md., March 02, 2021 (GLOBE NEWSWIRE) &#8212; NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a Virtual R&amp;D Update Event at 5:00 p.m. ET on Thursday, March 4. The event will be available via conference call and webcast. To listen to the call, please dial: US\/CANADA Toll-Free Dial-In Number: (877) 665-6632International Dial-In Number: (602) 563-8471Conference ID: 6773907 A live webcast of the event will be available through the Investors section of the company\u2019s website at www.nextcure.com. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days. &hellip; Continue reading &quot;REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-02T21:08:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021\",\"datePublished\":\"2021-03-02T21:08:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/\"},\"wordCount\":583,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/\",\"name\":\"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\",\"datePublished\":\"2021-03-02T21:08:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/","og_locale":"en_US","og_type":"article","og_title":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk","og_description":"BELTSVILLE, Md., March 02, 2021 (GLOBE NEWSWIRE) &#8212; NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a Virtual R&amp;D Update Event at 5:00 p.m. ET on Thursday, March 4. The event will be available via conference call and webcast. To listen to the call, please dial: US\/CANADA Toll-Free Dial-In Number: (877) 665-6632International Dial-In Number: (602) 563-8471Conference ID: 6773907 A live webcast of the event will be available through the Investors section of the company\u2019s website at www.nextcure.com. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days. &hellip; Continue reading \"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-02T21:08:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021","datePublished":"2021-03-02T21:08:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/"},"wordCount":583,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/","name":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=","datePublished":"2021-03-02T21:08:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4MzA1MyM0MDQ0ODExIzIxMjU4MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reminder-nextcure-to-host-virtual-rd-update-event-on-march-4-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"REMINDER: NextCure to Host Virtual R&amp;D Update Event on March 4, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/448842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=448842"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/448842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=448842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=448842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=448842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}